| Trial ID: | L4437 |
| Source ID: | NCT05322213
|
| Associated Drug: |
Thc
|
| Title: |
THC Effects on Glucose in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
NOT_YET_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: THC|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change in Glucose Uptake, The change in glucose uptake from placebo treatment to THC treatment as measure by the hyperinsulinemic/euglycemic clamp., 6 weeks|Change in Vascular Endothelial Function, The change in vascular endothelial function from placebo treatment to THC treatment as measured by flow mediated dilation (brachial artery diameter)., 6 weeks|Change in Vascular Endothelial Function, The change in vascular endothelial function from placebo treatment to THC treatment as measured by reactive hyperemia-peripheral arterial tonometry (reactive hyperemia index)., 6 weeks |
|
| Sponsor/Collaborators: |
Sponsor: University of California, San Diego | Collaborators: Center for Medicinal Cannabis Research
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2024-03-01
|
| Completion Date: |
2027-06-30
|
| Results First Posted: |
|
| Last Update Posted: |
2023-11-07
|
| Locations: |
UC San Diego Altman Clinical & Translational Research Institute, La Jolla, California, 92037, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT05322213
|
